Drug Database
Back to search

Netherlands· NL-a75f328bf0a9

Fintepla 2,2 mg/ml drank

A fenfluramine product containing fenfluramine hydrochloride, registered in Netherlands by UCB Pharma S.A.. The same ATC class is registered in 11 of our 19 countries.

ATC N03AX26

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedFintepla 2,2 mg/ml drankATCN03AX26REGISTER NO.NL-a75f328bf0a9PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fenfluramine hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Fenfluramine is registered in 11 of 19 countries.

Countries holding a registration under ATC N03AX26 (fenfluramine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search fenfluramine products by name

Fenfluramine · ATC N03AX26

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
FENFLURAMINE HYDROCHLORIDE
Manufacturer
UCB Pharma S.A.
Country
Netherlands (NL)
ATC code
N03AX26
ATC class
Fenfluramine
Defined daily dose
8 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/20/1491

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

349 interactions on record for fenfluramine.

Graded by severity as the source publishes them — 85 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check fenfluramine against other medicinesHow interaction checks work

Fenfluramine · interactions on record

349 records

  • 85 severe
  • 260 moderate
  • 4 minor

Most severe, free to view

  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe
  • PalonosetronA04AA05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fenfluramine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fenfluramine products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Fintepla
  • Liechtenstein · Fintepla
  • Norway · Fintepla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/82289c1f-cdb9-40b6-86b5-1e50fb0fc15b
GET /v1/drugs/82289c1f-cdb9-40b6-86b5-1e50fb0fc15b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Drank",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/fintepla-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Fenfluramine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp124535",
  "excipients": [
    "ARABISCHE GOM (E 414)",
    "CITROENZUUR 1-WATER (E 330)",
    "GLUCOSE (HYDRATATIEVORM ONBEKEND)",
    "HYDROXYETHYLCELLULOSE",
    "KERSENSMAAKSTOF",
    "MALTODEXTRINE",
    "NATRIUMETHYLPARAHYDROXYBENZOAAT (E 215)",
    "NATRIUMMETHYLPARAHYDROXYBENZOAAT (E 219)",
    "SUCRALOSE (E 955)",
    "TRIKALIUMCITRAAT 1-WATER (E 332)",
    "WATER VOOR INJECTIE",
    "ZWAVELDIOXIDE (E 220)"
  ],
  "substances": [
    "FENFLURAMINE HYDROCHLORIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2020/12/18",
  "procedure_number": "EMEA/H/C/003933",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/20/1491",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about fenfluramine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console